Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 8 (August)

1. Expression and regulation of WISP2 in rheumatoid arthritic synovium.
   Biochem Biophys Res Commun, 334(4): 973-8. [Abstract] [Full-text]
2. The role of Toll-like receptor signalling in the pathogenesis of arthritis.
   Cell Immunol, 233(2): 90-6. [Abstract] [Full-text]
3. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.
   Hum Mol Genet, 14(16): 2469-80. [Abstract] [Full-text]
4. Whole genome association study of rheumatoid arthritis using 27 039 microsatellites.
   Hum Mol Genet, 14(16): 2305-21. [Abstract] [Full-text]
5. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
   Acta Otolaryngol, 125(6): 671-3. [Abstract] [Full-text]
6. Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis.
   Amyloid, 12(1): 26-32. [Abstract] [Full-text]
7. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
   Arthritis Rheum, 52(8): 2541-8. [Abstract] [Full-text]
8. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score.
   Arthritis Rheum, 52(8): 2300-6. [Abstract] [Full-text]
9. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.
   Arthritis Rheum, 52(8): 2323-30. [Abstract] [Full-text]
10. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Arthritis Rheum, 52(8): 2313-22. [Abstract] [Full-text]
11. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.
    Arthritis Rheum, 52(8): 2331-42. [Abstract] [Full-text]
12. Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage.
    Arthritis Rheum, 52(8): 2284-92. [Abstract] [Full-text]
13. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes.
    Arthritis Rheum, 52(8): 2307-12. [Abstract] [Full-text]
14. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
    Arthritis Rheum, 52(8): 2506-12. [Abstract] [Full-text]
15. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.
    Arthritis Rheum, 52(8): 2263-71. [Abstract] [Full-text]
16. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: performance over five years in a primary care-based prospective study.
    Arthritis Rheum, 52(8): 2277-83. [Abstract] [Full-text]
17. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
    Arthritis Rheum, 52(8): 2447-51. [Abstract] [Full-text]
18. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
    Arthritis Rheum, 52(8): 2411-4. [Abstract] [Full-text]
19. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Arthritis Rheum, 52(8): 2272-6. [Abstract] [Full-text]
20. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Autoimmun Rev, 4(6): 389-94. [Abstract] [Full-text]
21. Rotator cuff repair in patients with rheumatoid arthritis.
    J Bone Joint Surg Am, 87(8): 1782-7. [Abstract] [Full-text]
22. Cervicothoracic extension osteotomy for chin-on-chest deformity in ankylosing spondylitis.
    J Bone Joint Surg Am, 87(8): 1732-8. [Abstract] [Full-text]
23. Decreased muscle strength and mobility of the neck in patients with rheumatoid arthritis and atlantoaxial disorders.
    Arch Phys Med Rehabil, 86(8): 1603-8. [Abstract] [Full-text]
24. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history.
    Am J Med, 118(8): 899-906. [Abstract] [Full-text]
25. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
    Cells Tissues Organs, 180(1): 22-30. [Abstract] [Full-text]
26. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
    Br J Dermatol, 153(2): 417-23. [Abstract] [Full-text]
27. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages.
    Clin Immunol, 116(3): 217-24. [Abstract] [Full-text]
28. Interventions for foot disease in rheumatoid arthritis: a systematic review.
    Arthritis Rheum, 53(4): 593-602. [Abstract] [Full-text]
29. Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.
    Arthritis Rheum, 53(4): 494-501. [Abstract] [Full-text]
30. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis.
    Arthritis Rheum, 53(4): 502-9. [Abstract] [Full-text]
31. Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis.
    Arthritis Rheum, 53(4): 603-8. [Abstract] [Full-text]
32. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
    Scand J Immunol, 62(1): 55-62. [Abstract] [Full-text]
33. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis.
    Ann Rheum Dis, 64(9): 1360-1. [Abstract] [Full-text]
34. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction.
    Ann Rheum Dis, 64(9): 1357-9. [Abstract] [Full-text]
35. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients.
    Arch Med Res, 36(5): 555-9. [Abstract] [Full-text]
36. Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population.
    J Pineal Res, 39(2): 201-5. [Abstract] [Full-text]
37. Long time interval between multiple sclerosis onset and occurrence of primary Sjögren's syndrome in a woman treated with interferon-beta.
    Acta Neurol Scand, 112(3): 194-6. [Abstract] [Full-text]
38. Combination treatment strategies in early rheumatoid arthritis.
    Ann Rheum Dis, 64(9): 1252-6. [Abstract] [Full-text]
39. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.
    Ann Rheum Dis, 64(9): 1294-8. [Abstract] [Full-text]
40. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
    Ann Rheum Dis, 64(9): 1288-93. [Abstract] [Full-text]
41. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
    Ann Rheum Dis, 64(9): 1316-20. [Abstract] [Full-text]
42. Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis.
    Ann Rheum Dis, 64(9): 1350-2. [Abstract] [Full-text]
43. Lamivudine is not effective in primary Sjögren's syndrome.
    Ann Rheum Dis, 64(9): 1326-30. [Abstract] [Full-text]
44. Treatment continuation in patients receiving biological agents or conventional DMARD therapy.
    Ann Rheum Dis, 64(9): 1274-9. [Abstract] [Full-text]
45. Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
    Ann Rheum Dis, 64(9): 1353-6. [Abstract] [Full-text]
46. Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(9): 1299-304. [Abstract] [Full-text]
47. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography.
    Ann Rheum Dis, 64(9): 1280-7. [Abstract] [Full-text]
48. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis.
    J Laryngol Otol, 119(8): 646-8. [Abstract] [Full-text]
49. Reactivation of antigen-induced arthritis in mice by oral administration of lipopolysaccharide.
    Scand J Immunol, 62(2): 117-22. [Abstract] [Full-text]
50. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
    Int Arch Allergy Immunol, 137(4): 315-8. [Abstract] [Full-text]
51. Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes.
    Cytokine, 31(5): 335-48. [Abstract] [Full-text]
52. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
    Rheumatology (Oxford), 44(9): 1181-5. [Abstract] [Full-text]
53. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
    Rheumatology (Oxford), 44(9): 1169-75. [Abstract] [Full-text]
54. Coping and psychological adjustment in recent-onset inflammatory polyarthritis: the role of gender and age.
    Rheumatology (Oxford), 44(9): 1166-8. [Abstract] [Full-text]
55. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis.
    Rheumatology (Oxford), 44(9): 1132-5. [Abstract] [Full-text]
56. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Rheumatology (Oxford), 44(9): 1140-4. [Abstract] [Full-text]
57. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis.
    Rheumatology (Oxford), 44(9): 1115-21. [Abstract] [Full-text]
58. Revision total knee arthroplasty with the Total Condylar III system in inflammatory arthritis.
    J Bone Joint Surg Br, 87(9): 1222-4. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.